168 related articles for article (PubMed ID: 797533)
1. Blocking and unblocking serum factors in neoplasia.
Bansal SC; Bansal BR; Boland JP
Curr Top Microbiol Immunol; 1976; 75():45-76. PubMed ID: 797533
[No Abstract] [Full Text] [Related]
2. Humoral factors abrogating cell-mediated immunity in the tumor-bearing host.
Baldwin RW; Robins RA
Curr Top Microbiol Immunol; 1975; 72():21-53. PubMed ID: 767057
[No Abstract] [Full Text] [Related]
3. Relationship between blocking and unblocking activity and tumor growth in vivo.
Sjögren HO; Bansal SC
Natl Cancer Inst Monogr; 1972 Dec; 35():231-5. PubMed ID: 4349148
[No Abstract] [Full Text] [Related]
4. The immunotherapy of cancer.
Parker CW
Pharmacol Rev; 1973 Jun; 25(2):325-42. PubMed ID: 4581047
[No Abstract] [Full Text] [Related]
5. Horizons in tumor immunology. A seminar.
Wilson RE; Alexander P; Rosenberg SA; Simmons RL
Arch Surg; 1974 Jul; 109(1):17-29. PubMed ID: 4834133
[No Abstract] [Full Text] [Related]
6. Cellular and humoral immune interactions during neoplastic development.
Baldwin RW; Bowen JG; Embleton MJ; Price MR; Robins RA
Johns Hopkins Med J Suppl; 1974; 3():393-407. PubMed ID: 4371716
[No Abstract] [Full Text] [Related]
7. [Immunology and cancer].
Brunner KT
Schweiz Med Wochenschr; 1973 Sep; 103(36):1249-52. PubMed ID: 4584090
[No Abstract] [Full Text] [Related]
8. In vitro testing in tumor immunotherapy.
Berkelhammer J
Semin Oncol; 1974 Dec; 1(4):397-408. PubMed ID: 4143489
[No Abstract] [Full Text] [Related]
9. The gordian knot of tumour immunology.
Amlot P
Guys Hosp Rep; 1974; 123(1):43-51. PubMed ID: 4549511
[No Abstract] [Full Text] [Related]
10. Tumor antigens and tumor-host relationships.
Baldwin RW; Price MR
Annu Rev Med; 1976; 27():151-63. PubMed ID: 779594
[No Abstract] [Full Text] [Related]
11. Immunologic mechanisms in the prevention and therapy of cancer.
Fleisher TA; Kersey JH
Am J Dis Child; 1974 Nov; 128(5):739-42. PubMed ID: 4608684
[No Abstract] [Full Text] [Related]
12. Cell-mediated immune reactions to tumor antigens with particular emphasis on immunity to human neoplasms.
Hellström I; Hellström KE
Cancer; 1974 Oct; 34(4 Suppl):suppl:1461-8. PubMed ID: 4417442
[No Abstract] [Full Text] [Related]
13. Suppression of cell-mediated cytotoxicity by lymphocytes from tumor-bearing animals.
Hellström I; Hellström KE; Kall MA; Nelson K; Pollack S
Transplant Proc; 1976 Jun; 8(2):255-64. PubMed ID: 936286
[No Abstract] [Full Text] [Related]
14. Lymphocyte-mediated immune responses in neoplasia.
Pilch YH; Golub SH
Am J Clin Pathol; 1974 Aug; 62(2):184-211. PubMed ID: 4602086
[No Abstract] [Full Text] [Related]
15. Incidence of cytotoxic antibodies in serum from neoplasia patients.
Abeatici S; Raso AM
Panminerva Med; 1975; 16(7-8):203-6. PubMed ID: 1109488
[No Abstract] [Full Text] [Related]
16. In vitro methods for assessment of antibody-mediated tumor immunity.
Levy NL; Amos DB; Solovieff GV; dos Reis AP
Natl Cancer Inst Monogr; 1972 Dec; 35():5-11. PubMed ID: 4349154
[No Abstract] [Full Text] [Related]
17. The role of immunology in the diagnosis and treatment of cancer.
Humphrey LJ; Pierce GE
Prog Clin Cancer; 1975; 6():15-36. PubMed ID: 53858
[No Abstract] [Full Text] [Related]
18. Immunologic aspects of malignancy: Factors of concern in the prospective candidate for immunotherapy.
Ablin RJ
Allergol Immunopathol (Madr); 1975; 3(2):105-8. PubMed ID: 1155313
[No Abstract] [Full Text] [Related]
19. [Tumor immunology].
Cerni CM
Subsid Med; 1974; 2():21-5. PubMed ID: 4606048
[No Abstract] [Full Text] [Related]
20. Transfer of antitumor immunity by "immune" RNA.
Pilch YH; Fritze D; Waldman SR; Kern DH
Curr Top Microbiol Immunol; 1975; 72():157-90. PubMed ID: 767056
[No Abstract] [Full Text] [Related]
[Next] [New Search]
